Insulin maintains glucose homeostasis by several mechanisms: a) suppression of hepatic glucose production; b) stimulation of splanchnic (hepatic) glucose uptake and c) stimulation of peripheral (muscle) glucose (non oxidative) and oxidation. The precise contribution of each of these pathways to overall insulin-induced insulin-mediated glucose metabolism in awake chronically catheterized rats. Moreover, by quantitating hepatic glucose production, liver and skeletal muscle glycogen synthesis and whole body glycolysis during the insulin clamp study, I am able to evaluate the contribution of each of these pathways to the overall glucose disposal under different metabolic conditions. Recently, I have investigated the impact of the insulinomimetic agents, lithium and vanadate, on insulin- mediated glucose metabolism. Since these elements mimic some, but not all insulin effects, and do not directly bind to the insulin receptor, they can be used as experimental probes to better understand the intracellular mechanisms of insulin action. The results of these studies have allowed us to identify the metabolic pathways responsible for the impaired in vivo insulin action in a diabetic rat model. With these considerations in mind, I propose to combine the data obtained from the in vivo studies with in vitro analysis of tissue homogenates from the same animals in the attempt to identify the rate-limiting step(s) and the intracellular mechanism(s) responsible for the impairment of each metabolic pathway.
The specific aims of the present proposal are: 1. To quantitate the contribution of different metabolic pathways to insulin-mediated glucose disposal in normal rats. 2. To identify the defective pathway(s) responsible for insulin resistance in diabetic rats. 3. To determine the rate-limiting step(s) of in vivo insulin action at different plasma insulin and glucose concentrations in normal and diabetic rats. 4. To delineate the influence of the route of the glucose administration on the pathways of glucose disposal in normal and diabetic rats. 5.To investigate the intracellular mechanism(s) of the lithium's and vanadate's insulinomimetic effects. 6.To quantitate modifications in enzyme activities following correction of hyperglycemia with different insulinomimetic agents.

Project Start
1991-08-01
Project End
1996-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Arrieta-Cruz, Isabel; Su, Ya; Gutiérrez-Juárez, Roger (2016) Suppression of Endogenous Glucose Production by Isoleucine and Valine and Impact of Diet Composition. Nutrients 8:79
Arrieta-Cruz, Isabel; Knight, Colette M; Gutiérrez-Juárez, Roger (2015) Acute Exposure of the Mediobasal Hypothalamus to Amyloid-?25-35 Perturbs Hepatic Glucose Metabolism. J Alzheimers Dis 46:843-8
Haeusler, Rebecca A; Hartil, Kirsten; Vaitheesvaran, Bhavapriya et al. (2014) Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat Commun 5:5190
Pereira, Sandra; Park, Edward; Mori, Yusaku et al. (2014) FFA-induced hepatic insulin resistance in vivo is mediated by PKC?, NADPH oxidase, and oxidative stress. Am J Physiol Endocrinol Metab 307:E34-46
Arrieta-Cruz, Isabel; Su, Ya; Knight, Colette M et al. (2013) Evidence for a role of proline and hypothalamic astrocytes in the regulation of glucose metabolism in rats. Diabetes 62:1152-8
Su, Ya; Lam, Tony K T; He, Wu et al. (2012) Hypothalamic leucine metabolism regulates liver glucose production. Diabetes 61:85-93
Kishore, P; Kehlenbrink, S; Hu, M et al. (2012) Xylitol prevents NEFA-induced insulin resistance in rats. Diabetologia 55:1808-12
Ren, Hongxia; Orozco, Ian J; Su, Ya et al. (2012) FoxO1 target Gpr17 activates AgRP neurons to regulate food intake. Cell 149:1314-26
Kishore, Preeti; Boucai, Laura; Zhang, Kehao et al. (2011) Activation of K(ATP) channels suppresses glucose production in humans. J Clin Invest 121:4916-20
Shishova, Ekaterina Y; Stoll, Janis M; Ersoy, Baran A et al. (2011) Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production. Hepatology 54:664-74

Showing the most recent 10 out of 17 publications